Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

2 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients - Immunosuppressive premedication

- 7/5/21 - 1 formulario, 31 itemgroups, 90 items, 1 idioma
Itemgroups: Antibodies: Anti-CD20, Antibodies: CD-22, Antibodies: CD-38, Antibodies: CD-52, Antibodies: Anti-CD79b, Antibodies: BLyS, Antibodies: CD19-BiTE, Antibodies: Complement inhibitors, Antibodies: Integrin antagonists, Antibodies: Interleukin inhibitors, Antibodies: TNF-alpha inhibitors, Other Antibodies, Inhibitors: Co-stimulation inhibitors, Inhibitors: Calcineurin inhibitors, Inhibitors: Interleukin inhibitor, Inhibitors: JAK inhibitors, Inhibitors: mTOR inhibitors, Inhibitor: PDE-4-inhibitor, Other Inhibitors, Recent: Checkpoint inhibitors, Chemotherapeutics: Antimetabolites, Chemotherapeutics: Cytostatics, Other Chemotherapeutics, Corticosteroids, Other immunosuppressive regimens: Fumarate, Other immunosuppressive regimens: Immunoglobulines, Other immunosuppressive regimens: Interferon, Immunosuppressive regimens: Other Multiple Sclerosis drugs, Other immunosuppressive regimens, Immunosuppressive drugs: Underlying disease, Is data entry for this section finished?
Study Title: LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients https://leoss.net Study Indication: COVID-19 Date: 19.03.2021 Published with permission by Prof. Dr. med. J.-J. Vehreschild. LEOSS, a multi-center cohort study, has been created to get more in-depth knowledge about the epidemiology and clinical course of patients infected with SARS-CoV-2. Initiated by the ESCMID Emerging Infections Task Force (EITaF) and the German Infectious Disease Society, and supported by all German Centers for Health Research (DZG), LEOSS has developed into an international network of contributors. Via an integrative research approach with anonymous recruitment and collection of routine data in an open science context, LEOSS is building a uniform clinical dataset and providing real-time analyses. For more information feel free to explore https://leoss.net/. This document is for immunosuppressive premedication. If a text field can't be filled out, note 'ND'.

Eligibility Acute Leukemia NCT01036009

- 7/12/15 - 1 formulario, 2 itemgroups, 13 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies; ODM derived from: https://clinicaltrials.gov/show/NCT01036009

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial